KRISTI MAYNARD: Open Payments
NPI 1821344037 · MADISON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 19 payments from 12 companies in 2025. Trend: 2023 $19 · 2024 $19 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Amgen Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: REXULTI, OTEZLA, XIFAXAN, TRELEGY ELLIPTA, Kerendia, The Cologuard Plus Collection Kit, NUCALA, YCANTH.
Industry payments across CT — which companies pay providers there.
